Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018
Dec 31, 2017
Total Revenue
155,054
170,911
174,386
184,305
Cost of Revenue
95,913
104,383
99,036
96,855
Gross Profit
59,141
66,528
75,350
87,450
Operating Expenses
Research Development
9,810
8,335
2,730
10,722
Selling General and Administrative
20,588
20,553
14,112
28,493
Non Recurring
--
--
--
1,100
Others
0
0
8,293
(1,100)
Total Operating Expenses
30,398
28,888
25,135
39,215
Operating Income or Loss
28,743
37,640
50,215
48,235
Income from Continuing Operations
Total Other Income/Expenses Net
(370,438)
(28,688)
(16,878)
4,611
Earnings Before Interest And Taxes
(341,695)
8,952
33,337
52,846
Interest Expense
21,433
21,194
22,842
20,686
Income Before Tax
(363,128)
(12,242)
10,495
32,160
Income Tax Expense
(75,600)
(883)
(2,275)
18,138
Minority Interest
--
0
--
--
Net Income From Continuing Ops
(287,528)
(11,359)
12,770
14,022
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(287,528)
(11,359)
12,770
14,022
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(287,528)
(11,359)
12,770
14,022